Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Clinical Evaluation, Patch Testing, and Quality of Life Assessment in Patients With Cosmetic Dermatitis
Harshavardhan Jampuram1, Aneet Mahendra1, Sanjeev Gupta1
1Dermatology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, IND.
Abstract:
Background Cosmetics have become an integral part of the contemporary lifestyle. Contact dermatitis (CD) is an inflammatory skin disease resulting from exposure to an external chemical present in cosmetics. A patch test is considered the criterion standard method for detecting CD. CD has been demonstrated to be detrimental to the quality of life (QoL). Objective The present study aims to investigate the clinical-epidemiological profile of CD and identify the possible allergens involved in it through patch testing. We also aim to assess the impact of QoL on patients presenting with CD. Methodology A total of 65 patients with CD were enrolled in the study. A comprehensive history of cosmetic products was obtained, along with dermatological and systemic examination. Patch testing was done to identify possible allergens with the Indian Cosmetic and Fragrance series and allergens from the Indian Standard Battery as and when required. A quality-of-life assessment was done using the Dermatology Life Quality Index (DLQI) questionnaire. Results The mean age of the patients was 43.2 ± 11.9 years, with a high preponderance of females (40; 61.5%). The most common cosmetic used was hair dye (45; 69.2%), followed by moisturizer/lotion/cream (23; 35.4%) and soap/shampoo/cleanser (16; 24.6%). The most prevalent site of allergy was the face (53; 81.5%), followed by the scalp (35; 53.8%), eyelids (33; 50.8%), and neck (22; 33.8%). The most common allergen was para-phenylenediamine (22; 33.8%), followed by fragrance mix (10; 15.4%) and Kathon CG (methylchloroisothiazolinone + methylisothiazolinone) (8; 12.3%). The mean DLQI score was 8.61 ± 5.36. Most patients had mild to moderate DLQI scores (45; 69.2%). Conclusion The present study was a prospective study that analyzed the clinical-epidemiological profile and impairment of QoL in CD. We identified the possible allergens involved in cosmetic CD by patch testing with the Indian cosmetic and fragrance series. We also assessed the impact on the quality of life in patients with cosmetic dermatitis. Further multicentric studies with ample sample sizes are required to validate the findings of this study.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...